Mr Bernard Wangamati, LPN | |
917 Suffield St, Agawam, MA 01001-2902 | |
(571) 340-5812 | |
Not Available |
Full Name | Mr Bernard Wangamati |
---|---|
Gender | Male |
Speciality | Licensed Practical Nurse |
Location | 917 Suffield St, Agawam, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265982714 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | LN87881 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Bernard Wangamati, LPN 917 Suffield St, Agawam, MA 01001-2902 Ph: (571) 340-5812 | Mr Bernard Wangamati, LPN 917 Suffield St, Agawam, MA 01001-2902 Ph: (571) 340-5812 |
News Archive
Researchers at Johns Hopkins say they have gleaned two important new clues in the fight against Parkinson's disease: that blocking an enzyme called c-Abl prevents the disease in specially bred mice, and that a chemical tag on a second protein may signal the disorder's presence and progression.
Lumpectomy plus radiation was associated with a small clinical benefit in reduced risk of breast cancer death compared with lumpectomy or mastectomy alone in women with ductal carcinoma in situ, a noninvasive early form of breast cancer.
"Abortion was one of the most contentious issues in this debate from the very beginning, more than a year ago. A longstanding law — the Hyde Amendment — bars federal funds from being used to pay for elective abortions. It's an agreement between anti-abortion and pro-abortion rights lawmakers that is so delicate it could balance on a pin."
The American College of Physicians (ACP) today urged Congressional leaders to "reach agreement on a legislative pathway to provide affordable care to all Americans and ensure that they have access to primary care physicians and other specialties facing shortages."
Botox- (onabotulinum toxin-A) injections to the bladder are as effective as medication for treating urinary urgency incontinence in women, but the injection is twice as likely to completely resolve symptoms. These findings were published in the latest issue of The New England Journal of Medicine by a National Institutes of Health clinical trials network including Loyola University Chicago Stritch School of Medicine (SSOM).
› Verified 3 days ago